Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis
Johanna M. Pellikainen(University of Eastern Finland), Veli‐Matti Kosma(University of Eastern Finland), Matti Eskelinen(University of Eastern Finland), Jari Kellokoski, Vesa Kataja(Kuopio University Hospital), Kirsi Ropponen
Cited by 341
Related Papers
Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer
|New England Journal of Medicine|2006|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2010|600
Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival
|American Journal Of Pathology|2000|496
A recurrent mutation in PALB2 in Finnish cancer families
|Nature|2007|461